My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 341

    1.

    Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial.

    Lin JL, Ho HH, Yu CC.

    Ann Intern Med. 1999 Jan 5;130(1):7-13.PMID: 9890856 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Environmental lead exposure and progressive renal insufficiency.

    Lin JL, Tan DT, Hsu KH, Yu CC.

    Arch Intern Med. 2001 Jan 22;161(2):264-71.PMID: 11176742 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.

    Lin JL, Lin-Tan DT, Hsu KH, Yu CC.

    N Engl J Med. 2003 Jan 23;348(4):277-86.PMID: 12540640 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.

    Lin-Tan DT, Lin JL, Yen TH, Chen KH, Huang YL.

    Nephrol Dial Transplant. 2007 Oct;22(10):2924-31. Epub 2007 Jun 7.PMID: 17556414 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Low-level environmental exposure to lead and progressive chronic kidney diseases.

    Lin JL, Lin-Tan DT, Li YJ, Chen KH, Huang YL.

    Am J Med. 2006 Aug;119(8):707.e1-9.PMID: 16887418 [PubMed - indexed for MEDLINE]Related articles

    6.

    Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes.

    Lin JL, Lin-Tan DT, Yu CC, Li YJ, Huang YY, Li KL.

    Kidney Int. 2006 Jun;69(11):2049-56.PMID: 16641918 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout.

    Lin JL, Yu CC, Lin-Tan DT, Ho HH.

    Kidney Int. 2001 Jul;60(1):266-71.PMID: 11422760 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?

    Ahmed A.

    J Am Geriatr Soc. 2002 Jul;50(7):1297-300.PMID: 12133029 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.

    Dietrich KN, Ware JH, Salganik M, Radcliffe J, Rogan WJ, Rhoads GG, Fay ME, Davoli CT, Denckla MB, Bornschein RL, Schwarz D, Dockery DW, Adubato S, Jones RL; Treatment of Lead-Exposed Children Clinical Trial Group.

    Pediatrics. 2004 Jul;114(1):19-26.PMID: 15231903 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study.

    Yu CC, Lin JL, Lin-Tan DT.

    J Am Soc Nephrol. 2004 Apr;15(4):1016-22.PMID: 15034104 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Environmental lead exposure and urate excretion in the general population.

    Lin JL, Tan DT, Ho HH, Yu CC.

    Am J Med. 2002 Nov;113(7):563-8.PMID: 12459402 [PubMed - indexed for MEDLINE]Related articles

    12.

    Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.

    Siu YP, Leung KT, Tong MK, Kwan TH.

    Am J Kidney Dis. 2006 Jan;47(1):51-9.PMID: 16377385 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.

    Huber W, Ilgmann K, Page M, Hennig M, Schweigart U, Jeschke B, Lutilsky L, Weiss W, Salmhofer H, Classen M.

    Radiology. 2002 Jun;223(3):772-9.PMID: 12034949 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Occult lead intoxication as a cause of hypertension and renal failure.

    Sánchez-Fructuoso AI, Torralbo A, Arroyo M, Luque M, Ruilope LM, Santos JL, Cruceyra A, Barrientos A.

    Nephrol Dial Transplant. 1996 Sep;11(9):1775-80.PMID: 8918621 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Elevated lead burden in Chinese patients without occupational lead exposure.

    Lin JL, Lim PS.

    Miner Electrolyte Metab. 1992;18(1):1-5.PMID: 1406500 [PubMed - indexed for MEDLINE]Related articles

    16.

    Reversible hypothyroidism with EDTA chelation therapy in a patient with elevated lead burden and chronic renal insufficiency.

    Lin JL, Shih FC.

    Nephrol Dial Transplant. 1997 Feb;12(2):364-5. No abstract available. PMID: 9132667 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Body lead stores and urate excretion in men with chronic renal disease.

    Lin JL, Huang PT.

    J Rheumatol. 1994 Apr;21(4):705-9.PMID: 8035397 [PubMed - indexed for MEDLINE]Related articles

    18.

    Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

    Bakris GL, Weir MR.

    Arch Intern Med. 2000 Mar 13;160(5):685-93.PMID: 10724055 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Chronic lead poisoning: a "forgotten" cause of renal disease.

    Benjelloun M, Tarrass F, Hachim K, Medkouri G, Benghanem MG, Ramdani B.

    Saudi J Kidney Dis Transpl. 2007 Mar;18(1):83-6.PMID: 17237897 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.

    Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.

    Kidney Int. 2000 Feb;57(2):590-600.PMID: 10652036 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity